Literature DB >> 12473529

[Aetiologic factors and clinical features associated with thrombocytopenia in Cameroonese adults: the importance of Plasmodium falciparum malaria].

Dora Mbanya1, Jean-Baptiste Tapko, François Azowe, Lazare Kaptue.   

Abstract

In order to determine the main aetiologies associated with thrombocytopenia in a hospital setting of Cameroon, 180 adults with platelet counts <100x10(9)/L were examined and screened for a full blood count, thick and thin blood films, basic coagulation tests (activated partial thromboplastine time, a one-stage Quick's prothrombin time and a bleeding time), an HIV screening test as well as a bone marrow aspirate using standard methods. Other tests were selectively done as dictated by the suspected diagnosis. The major clinical findings among 180 cases included fever >37.5 C (53.9%), splenomegaly (45.6%) and haemorrhage (30.6%). The main laboratory findings were anaemia (defined as haemoglobin (Hb) <11g/dL) in 80.6% of cases and a positive thick blood film (all confirmed to be P. falciparum) in 30.6% of cases. Out of the 18 different aetiologies associated with a low platelet count in the group studied, malaria appears as the unique cause in 22.2% of cases. Petechial bleeding, bruising and epistaxis were the major forms of bleeding involved (69.1%, 27.3%, and 23.6% respectively). However, only 3 cases diagnosed with malaria showed any form of bleeding (mean malaria parasite densities >15,000/muL of blood in each case). No other haemostatic abnormalities were observed. It may be cost-effective for patients with low platelet counts in malarial regions to be systematically screened for malaria parasites.

Entities:  

Mesh:

Year:  2002        PMID: 12473529

Source DB:  PubMed          Journal:  Sante        ISSN: 1157-5999


  1 in total

1.  Haemostatic trends in HIV-infected individuals in Yaoundé, Cameroon: a pilot study.

Authors:  Larissa Tene; Claude T Tagny; Annick Mintya-Ndoumba; Victor N Fossi; Dora Mbanya
Journal:  Blood Coagul Fibrinolysis       Date:  2014-07       Impact factor: 1.276

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.